AMD at risk of a breakdown after Monday's dip >>> READ MORE


Recent Articles

iShares Nasdaq Biotechnology Index (ETF) (IBB): The Quick Guide to IBB

The $8 billion-plus iShares Nasdaq Biotechnology ETF (IBB) has a deep bench relative to other biotechnology funds. Is IBB right for you? More 

Go Long the iShares Nasdaq Biotechnology Index (ETF) (IBB) ETF With Confidence

The healthcare sector, after being the whipping boy of the elections, can find footing. Sell downside risk in the IBB ETF for easy income. More 

3 Biotech Trades for the Faux Doomsday Scenario

Biotech stocks have been a political football throughout the campaign and even now. Sell risk against the fear and the hope for a profit. More 

IShares Nasdaq Biotechnology Index (ETF) (IBB): Short the Near-Term Action in the IBB ETF

Drug stocks have been hated by traders for more than a year, but that feeling is abating. Use long-term value to short IBB over the near term. More 

Biogen Inc (BIIB): Profit From the BIIB Stock Bears

Love it or hate it, the severe chop in Big Pharma presents opportunities to create income. Sell risk against value levels in Biogen (BIIB) stock. More 

Is Now the Time to Buy Into These 5 Biotech ETFs?

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out More 

Illumina, Inc. (ILMN) Stock Is Nearing Breakout Territory

Illumina (ILMN) looks ripe for a break higher after ILMN stock spent the majority of the past two months in a sideways range. More